1. Home
  2. LPCN vs ARBB Comparison

LPCN vs ARBB Comparison

Compare LPCN & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • ARBB
  • Stock Information
  • Founded
  • LPCN 1997
  • ARBB 1997
  • Country
  • LPCN United States
  • ARBB Singapore
  • Employees
  • LPCN N/A
  • ARBB N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • LPCN Health Care
  • ARBB Technology
  • Exchange
  • LPCN Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • LPCN 16.4M
  • ARBB 18.5M
  • IPO Year
  • LPCN N/A
  • ARBB 2023
  • Fundamental
  • Price
  • LPCN $3.24
  • ARBB $0.77
  • Analyst Decision
  • LPCN Strong Buy
  • ARBB
  • Analyst Count
  • LPCN 1
  • ARBB 0
  • Target Price
  • LPCN $10.00
  • ARBB N/A
  • AVG Volume (30 Days)
  • LPCN 10.5K
  • ARBB 6.8M
  • Earning Date
  • LPCN 03-13-2025
  • ARBB 04-26-2025
  • Dividend Yield
  • LPCN N/A
  • ARBB N/A
  • EPS Growth
  • LPCN N/A
  • ARBB N/A
  • EPS
  • LPCN N/A
  • ARBB N/A
  • Revenue
  • LPCN $11,198,144.00
  • ARBB $12,334,474.00
  • Revenue This Year
  • LPCN N/A
  • ARBB N/A
  • Revenue Next Year
  • LPCN $37.31
  • ARBB N/A
  • P/E Ratio
  • LPCN N/A
  • ARBB N/A
  • Revenue Growth
  • LPCN N/A
  • ARBB N/A
  • 52 Week Low
  • LPCN $2.91
  • ARBB $0.22
  • 52 Week High
  • LPCN $11.79
  • ARBB $1.40
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 41.52
  • ARBB 49.88
  • Support Level
  • LPCN $3.00
  • ARBB $0.65
  • Resistance Level
  • LPCN $3.57
  • ARBB $0.83
  • Average True Range (ATR)
  • LPCN 0.24
  • ARBB 0.07
  • MACD
  • LPCN -0.00
  • ARBB -0.01
  • Stochastic Oscillator
  • LPCN 23.29
  • ARBB 21.72

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: